Theraclone Sciences Announces Identification of New Vulnerable Site on HIV Using Antibodies

Study Published in Immunity in Collaboration with The Scripps Research Institute and IAVI April 25, 2014 Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, today announced the publication of data in the May issue of Immunity regarding antibodies with significant potency and breadth against human immunodeficiency virus (HIV). The study, titled “Broadly neutralizing HIV antibodies define a novel glycan-dependent epitope on the …

How To Make A HIV Vaccine

This week marked 30 years since the public announcement that the cause of AIDS had been discovered. But how close are we to defeating HIV? And what sort of vaccine will help us to do this? Well there are a number of different approaches to the creation of a HIV vaccine, some of which look to stop patients from contracting …